EQRx, Inc. (EQRX) Financial Statements (2026 and earlier)

Company Profile

Business Address 50 HAMPSHIRE STREET
CAMBRIDGE, MA 02139
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,300,000,0001,300,000,0001,400,000,0001,500,000,0001,600,000,0001,623,268,000
Cash and cash equivalent247,500,000368,358,000494,136,000998,022,000864,436,0001,623,268,000
Short-term investments1,014,056,000957,584,000905,150,000501,326,000692,911,000 
Other undisclosed cash, cash equivalents, and short-term investments38,444,000(25,942,000)714,000652,00042,653,000 
Restricted cash and investments      
Other undisclosed current assets(15,659,000)54,978,00028,086,00023,990,000(11,709,000)31,992,000
Total current assets:1,284,341,0001,354,978,0001,428,086,0001,523,990,0001,588,291,0001,655,260,000
Noncurrent Assets
Operating lease, right-of-use asset 2,660,0003,238,0003,804,0004,355,0004,889,0002,084,000
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 2,316,0002,590,0002,627,0001,794,0001,516,0001,611,000
Restricted cash and investments 633,000633,000633,000633,000633,000633,000
Other noncurrent assets17,448,00018,516,00015,866,0008,641,0008,950,00010,532,000
Other undisclosed noncurrent assets4,000,0004,000,0004,000,0004,000,0004,000,0004,000,000
Total noncurrent assets:27,057,00028,977,00026,930,00019,423,00019,988,00018,860,000
TOTAL ASSETS:1,311,398,0001,383,955,0001,455,016,0001,543,413,0001,608,279,0001,674,120,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities54,394,00057,516,00049,546,00060,163,00052,636,00054,008,000
Accounts payable6,586,00020,731,00019,950,00014,063,00013,019,0007,323,000
Accrued liabilities47,808,00036,785,00029,596,00046,100,00039,617,00046,685,000
Other undisclosed current liabilities2,430,0002,368,0002,370,0002,496,0002,619,0002,629,000
Total current liabilities:56,824,00059,884,00051,916,00062,659,00055,255,00056,637,000
Noncurrent Liabilities
Long-term debt and lease obligation:    2,060,0002,645,000 
Liabilities, other than long-term debt2,709,0006,080,0008,621,00062,178,00059,472,00051,267,000
Operating lease, liability 215,000849,0001,461,0002,060,0002,645,000 
Business combination, contingent consideration, liability2,494,0005,231,0007,160,00062,178,00059,472,00051,267,000
Other undisclosed noncurrent liabilities3,547,0003,680,0005,617,00016,554,00016,406,00017,639,000
Total noncurrent liabilities:6,256,0009,760,00014,238,00080,792,00078,523,00068,906,000
Total liabilities:63,080,00069,644,00066,154,000143,451,000133,778,000125,543,000
Equity
Equity, attributable to parent1,248,318,0001,314,311,0001,388,862,0001,399,962,0001,474,501,0001,548,577,000
Common stock49,00049,00049,00049,00049,00049,000
Additional paid in capital1,931,231,0001,924,318,0001,916,550,0001,906,947,0001,896,797,0001,886,294,000
Accumulated other comprehensive income (loss)134,00084,000(148,000)(1,622,000)(2,025,000)8,000
Accumulated deficit(683,096,000)(610,140,000)(527,589,000)(505,412,000)(420,320,000)(337,774,000)
Total equity:1,248,318,0001,314,311,0001,388,862,0001,399,962,0001,474,501,0001,548,577,000
TOTAL LIABILITIES AND EQUITY:1,311,398,0001,383,955,0001,455,016,0001,543,413,0001,608,279,0001,674,120,000

Income Statement (P&L) (USD)
Annual | Quarterly

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Operating expenses(91,836,000)(101,798,000)(100,730,000)(90,366,000)(79,090,000)(85,691,000)
Operating loss:(91,836,000)(101,798,000)(100,730,000)(90,366,000)(79,090,000)(85,691,000)
Nonoperating income (expense)18,880,00019,247,00078,553,0005,274,000(3,456,000)106,417,000
Other nonoperating income (expense)(8,000)(12,000)(21,000)(32,000)(526,000)514,000
Income (loss) from continuing operations:(72,956,000)(82,551,000)(22,177,000)(85,092,000)(82,546,000)20,726,000
Income (loss) before gain (loss) on sale of properties:✕✕✕✕(85,092,000)(82,546,000)20,726,000
Net income (loss) attributable to parent:(72,956,000)(82,551,000)(22,177,000)(85,092,000)(82,546,000)20,726,000
Undistributed earnings (loss) allocated to participating securities, basic      (692,000)
Net income (loss) available to common stockholders, basic:(72,956,000)(82,551,000)(22,177,000)(85,092,000)(82,546,000)20,034,000
Other undisclosed net income available to common stockholders, diluted      29,000
Net income (loss) available to common stockholders, diluted:(72,956,000)(82,551,000)(22,177,000)(85,092,000)(82,546,000)20,063,000

Comprehensive Income (USD)
Annual | Quarterly

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(72,956,000)(82,551,000)(22,177,000)(85,092,000)(82,546,000)20,726,000
Comprehensive income (loss):(72,956,000)(82,551,000)(22,177,000)(85,092,000)(82,546,000)20,726,000
Other undisclosed comprehensive income (loss), net of tax, attributable to parent50,000232,0001,474,000403,000(2,033,000)7,000
Comprehensive income (loss), net of tax, attributable to parent:(72,906,000)(82,319,000)(20,703,000)(84,689,000)(84,579,000)20,733,000

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: